These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34686)

  • 1. Percutaneous absorption: in vivo experiments.
    Albery WJ; Hadgraft J
    J Pharm Pharmacol; 1979 Mar; 31(3):140-7. PubMed ID: 34686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of glycerol on the percutaneous absorption of methyl nicotinate.
    Hadgraft J; Hadgraft JW; Sarkany I
    Br J Dermatol; 1972 Jul; 87(1):30-6. PubMed ID: 5043196
    [No Abstract]   [Full Text] [Related]  

  • 3. Noninvasive assessments of the percutaneous absorption of methyl nicotinate in humans.
    Guy RH; Wester RC; Tur E; Maibach HI
    J Pharm Sci; 1983 Sep; 72(9):1077-9. PubMed ID: 6631699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time of erythema onset after application of methyl nicotinate ointments as response parameter: influence of penetration kinetics and enhancing agents.
    Remane Y; Leopold CS
    Skin Pharmacol Physiol; 2006; 19(6):303-10. PubMed ID: 16931897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between percutaneous penetration of methyl nicotinate and sensitive skin, using laser Doppler imaging.
    Issachar N; Gall Y; Borrel MT; Poelman MC
    Contact Dermatitis; 1998 Oct; 39(4):182-6. PubMed ID: 9817223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous absorption: theoretical description.
    Albery WJ; Hadgraft J
    J Pharm Pharmacol; 1979 Mar; 31(3):129-39. PubMed ID: 34685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeation, metabolism and site of action concentration of nicotinic acid derivatives in human skin. Correlation with topical pharmacological effect.
    Müller B; Kasper M; Surber C; Imanidis G
    Eur J Pharm Sci; 2003 Oct; 20(2):181-95. PubMed ID: 14550884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of ointment formulation on skin erythema induced by nicotinate esters.
    Realdon N; Ragazzi E; Dal Zotto M; Ragazzi E
    Pharmazie; 1995 Sep; 50(9):603-6. PubMed ID: 7480096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin penetration of nicotinic acid, methyl nicotinate, and butyl nicotinate in the guinea pig--comparison of in vivo and excised skin, and the effects of four dermatologic conditions.
    Osamura H; Jimbo Y; Ishihara M
    J Dermatol; 1984 Oct; 11(5):471-81. PubMed ID: 6397492
    [No Abstract]   [Full Text] [Related]  

  • 10. Percutaneous penetration of nicotinates: in vivo and in vitro measurements.
    Guy RH; Carlström EM; Bucks DA; Hinz RS; Maibach HI
    J Pharm Sci; 1986 Oct; 75(10):968-72. PubMed ID: 3795027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate of absorption and duration of action of four different solutions of methyl nicotinate.
    Fountain RB; Baker BS; Hadgraft JW; Sarkany I
    Br J Dermatol; 1969 Mar; 81(3):202-6. PubMed ID: 5775069
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles.
    Puglia C; Esposito E; Menegatti E; Nastruzzi C; Rizza L; Cortesi R; Bonina F
    J Pharm Pharmacol; 2005 Sep; 57(9):1169-76. PubMed ID: 16105237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid radial transport of methyl nicotinate in the dermis.
    Guy RH; Maibach HI
    Arch Dermatol Res; 1982; 273(1-2):91-5. PubMed ID: 7184475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous absorption of nicotinic acid derivatives in vitro.
    Dal Pozzo A; Donzelli G; Liggeri E; Rodriguez L
    J Pharm Sci; 1991 Jan; 80(1):54-7. PubMed ID: 2013851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous absorption of nicotinic acid esters. Influence of vehicles].
    Henschel V; Jaminet F
    J Pharm Belg; 1972; 27(6):743-54. PubMed ID: 4665017
    [No Abstract]   [Full Text] [Related]  

  • 16. The percutaneous absorption of alkyl methyl sulfoxides.
    Sekura DL; Scala J
    Adv Biol Skin; 1972; 12():257-69. PubMed ID: 4665395
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics of release and simulated absorption of methyl nicotinate from different ointment formulations: in vitro-in vivo correlations.
    Realdon N; Ragazzi E; Dal Zotto M; Ragazzi E
    Pharmazie; 1996 Feb; 51(2):113-6. PubMed ID: 8720806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of processing conditions in the manufacture of O/W creams: II. Effect on drug availability.
    Realdon N; Ragazzi E; Morpurgo M; Ragazzi E
    Farmaco; 2002 May; 57(5):349-53. PubMed ID: 12058808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery.
    Tashtoush BM; Bennamani AN; Al-Taani BM
    Pharm Dev Technol; 2013; 18(4):834-43. PubMed ID: 23030413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous penetration of methyl nicotinate from ointments using the laser Doppler technique: bioequivalence and enhancer effects.
    Remane Y; Leopold CS; Maibach HI
    J Pharmacokinet Pharmacodyn; 2006 Dec; 33(6):719-35. PubMed ID: 17006769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.